Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations
The timing of benefit and the timing of loss both matter
+8% Power Output Meta-analyses show 515% strength gains over 4-week loading
Research Findings The clinical research portfolio for semaglutide is exceptionally comprehensive, spanning multiple large-scale, international, randomized controlled trials
Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier
Chiu and your anesthesia team if you have: Nausea or vomiting Constipation or bloating Abdominal pain or reflux A recent dose increase A newly started GLP-1 medication Poor appetite or low protein intake Rapid weight loss Diabetes or blood sugar changes A history of gastroparesis or slow digestion These details help your team decide whether to move forward, need a modified plan, or wait until symptoms improve
